Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Total Current Liabilities (2016 - 2025)

Angiodynamics (ANGO) has disclosed Total Current Liabilities for 15 consecutive years, with $72.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 18.77% year-over-year to $72.0 million, compared with a TTM value of $72.0 million through Nov 2025, down 18.77%, and an annual FY2025 reading of $76.2 million, down 16.41% over the prior year.
  • Total Current Liabilities was $72.0 million for Q4 2025 at Angiodynamics, up from $68.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $91.2 million in Q2 2024 and bottomed at $49.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $70.2 million, with a median of $72.8 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities surged 41.05% in 2023, then decreased 18.77% in 2025.
  • Year by year, Total Current Liabilities stood at $54.5 million in 2021, then surged by 35.05% to $73.6 million in 2022, then grew by 6.08% to $78.0 million in 2023, then increased by 13.53% to $88.6 million in 2024, then fell by 18.77% to $72.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for ANGO at $72.0 million in Q4 2025, $68.3 million in Q3 2025, and $76.2 million in Q2 2025.